Skip to main content
. 2021 May 2;13(9):2190. doi: 10.3390/cancers13092190

Figure 3.

Figure 3

Comparison of receiver operating characteristics (ROC) curves (A) and predictive performance (B) from peptide factor 4 (PF454–62), inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4429–438), apolipoprotein E (APOE198–207), and combinations of the three biomarkers with logistic regression and random forest in healthy controls (HCs) versus early-stage colorectal cancer (CRC), HC versus late-stage CRC, and HC versus all-stage CRC.